Document is current
Any future updates will be listed below
-
Authors
Moyes, Jocelyn https://orcid.org/0000-0001-8040-1717
Tempia, Stefano
Walaza, Sibongile
McMorrow, Meredith L.
Treurnicht, Florette
Wolter, Nicole
von Gottberg, Anne
Kahn, Kathleen
Cohen, Adam L.
Dawood, Halima
Variava, Ebrahim
Cohen, Cheryl
-
Funding
Funding for this research was provided by:
Centers for Disease Control and Prevention (1U01IP001160))
PATH (GAT.1890-01665909-SUB)
- License Information
-
More Information
Article History
Received: 23 September 2022
Accepted: 27 March 2023
First Online: 11 April 2023
Declarations
:
: The SARI and SRI protocol was approved by the University of the Witwatersrand Human Research Ethics Committee (HREC) and the University of KwaZulu-Natal Human Biomedical Research Ethics Committee (BREC) protocol numbers M081042 and BF157/08 respectively. The ILI protocol was approved by HREC and BREC protocol numbers M120133 and BF080/12. respectively. The healthcare utilization survey was approved by HREC M120367 and BREC BE209/13. This surveillance was deemed non-research by the United States Centers for Disease Control and Prevention (non-research determination number: 2012–6197). All participants in the surveillance program gave written informed consent to participate.
: The authors report no conflict of interest, other than the source of funding noted above.
